top of page
COBTH in the News
NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker Study
April 15, 2021
GenomeWeb
NEW YORK – NanoView Biosciences said on Thursday that it has signed an agreement with Beth Israel Deaconess Medical Center to study biomarkers carried by exosomes in patients undergoing immune checkpoint inhibitor therapy (ICIT) for cancer.
- 54Page 49
bottom of page